Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Last NR is two weeks old.
View:
Post by Lesalpes29 on Sep 17, 2024 8:37am

Last NR is two weeks old.

Really need an other good one. A possible deal on the viruses side? GL
Comment by Beano349 on Sep 17, 2024 11:50am
Thr NRs come out right before they need to raise money, so no NRs means they are not in need at this very moment. 
Comment by CAinPlap on Sep 17, 2024 1:20pm
I had an email exchange with Matthew. Coles notes is we raised just over $500K and are still on track for Pre BTD this month. With regards to the $10 million limit of last PP, here is his reply: We have multiple $10M+ interested investors at varying levels of interest, they will likely do an offering on there own, but we set the limit of this private placement for up to $10M due to securities ...more  
Comment by DJDawg on Sep 17, 2024 1:26pm
Great work! Just what the board was waiting to hear an update on. Thanks CaP! What is the monthly burn rate again? 500 K will get them how far?
Comment by riverrrow on Sep 17, 2024 1:30pm
Thank you for the update.  With only $500,000 raised this pp, expect another pp late October or early November.
Comment by Oilminerdeluxe on Sep 17, 2024 1:30pm
Thanks.
Comment by DJDawg on Sep 17, 2024 1:53pm
So unless there is something more to the inevitable NR about the 500 k, this is how TLT typically would play out. Share priced drifts 0.16-0.2. Whenever up to 0.2 expect some big dumps as accred people offload and build up for the next PP buy The only risk to the accred people is if they announce some source of cash that won't need PP then those accred people would likely pile back on ...more  
Comment by StevenBirch on Sep 17, 2024 3:06pm
Great work by Cain. The financing talk is nice but the biggest thing is that pre-BTD is on schedule for this month, getting BTD solves everything financially.
Comment by tdon1229 on Sep 19, 2024 12:56pm
Steven, RE your statement that "getting BTD solves everything financially."   BTD will be nice, but they need AA to be able to charge for their treatment and begin generating revenues even during the clinical trial. The FDA is being extra cautious because of their recent (2016-2021) experience of granting BTD and AA based on preliminary and unverified data, then having to ...more  
Comment by StevenBirch on Sep 19, 2024 1:53pm
By financially I just meant that if there are multiple people waiting to invest $10+ million they would be waiting for BTD. Just a guess on my part but I think that is exactly what they are waiting for. It's one thing to throw in $100-200K in a PP, still not chicken feed, vs a larger amount like $10 million.
Comment by BlueFranky on Sep 17, 2024 1:41pm
Nice dig Cap! ..soon
Comment by Tapps21 on Sep 17, 2024 3:30pm
Multiple $10 million+ interested investors?? Let's go already. This could be life changing ACT for hundreds if not thousands of humans.  And for once, I hope we hit those milestones. It's been a long, long wait and that pot of gold at the end of the rainbow is (hopefully) just around the corner.  GLTA
Comment by N0taP00p on Sep 17, 2024 3:38pm
CAinPlap: Thank you for the update. So the gist of it is that they want some money in the bank before they negotiate with these bigger $10M investment firms. $500K is way better than what they got last time. If pre-BTD is on schedule, best combination of news we've heard in a while. Thanks again. Looking forward to that next NR.   
Comment by wildbird1 on Sep 18, 2024 8:19am
Thanks CAinPlap, very reassuring post. In your post it said'' We have multiple $10 M+ interested investors at varying levels of interest''. That is huge... 1) It does imply that financing is not a problem. 2) It is almost as if TLT is saying, they could possibly do a few $500K financing, until they get  the FDA BTD approval, and thus limiting dillution. I love your post. .
Comment by Lesalpes29 on Sep 18, 2024 8:49am
Reassuring and love it too. Thank you for your posts. GL
Comment by Kingpin68 on Sep 18, 2024 10:04am
It's intriguing, having potential 10 mill plus investors sniffing around. If it were me, I'd at least want to see that pre BTD has been accepted by the FDA, seems obvious right. Then the purse strings may open up. BTD altogether, well that's even easier to empty the piggy bank.
Comment by Legit62 on Sep 18, 2024 10:33am
These investors were probably assured BTD is imminent and close, they want a piece of the pie
Comment by reconsider on Sep 18, 2024 10:06am
If the money is not in Theralase's bank account, 'multiple $10M+ interested investors' means little to me. If BTD is granted, no problem, but if for whatever reason it is not, we will be screwed. I don't know where the strategy comes from (either TLT preferring to negotiate better terms after BTD or investor wanting in after BTD derisking) but facing this moment without a big ...more  
Comment by Legit62 on Sep 18, 2024 10:34am
Great points, i would say all 
Comment by wildbird1 on Sep 18, 2024 10:35am
Bottom of CAinPlab post it said'' We are working on a number of fronts to achieve proper capitalization...and hope to be able to update the market on one of these shortly if achieved''. The word shortly imply that TLT is seriously working on a deal, and we could be seeing news on this deal before long(if achieved). Interesting...
Comment by CAinPlap on Sep 18, 2024 3:25pm
Unless we get a significant share price increase on either the BTD submission or another catalyst like herpes vaccine, I hope our funding comes in the form of government grants or debt. $10 million would get 20 - 25% of the company at current prices. Yes I do know how hard/risky it is to get loans without revenue but hopefully our revenue will soon follow.
Comment by Dumbeldorfwhite on Sep 19, 2024 10:48pm
We ll see soon enough if you re a bull thrower or if you re telling the truth. Still no BTD and now PP news 1.5 weeks now people 
Comment by DeathXray33 on Sep 20, 2024 7:49am
@ 1.544 mill now
Comment by DeathXray33 on Sep 17, 2024 3:24pm
"The global herpes simplex virus treatment market size was estimated at USD 2.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030." ---------------------------- "The prevalence of herpes simplex virus (HSV) infection is on the rise. According to an estimate from WHO, as of April 2023 approximately 3.7 billion people under age ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250